Monday, March 10, 2014
Add My Products
Custom microRNA cloning (1)
Custom microRNA expression profiling on biological (or patient) samples (1)
Custom microRNA target identification/validation (1)
microRNA amplification/cloning kits (0)
MicroRNA delivery (5)
microRNA down-regulating oligos (0)
microRNA down-regulation constructs (built in a vector-based system) (0)
microRNA expression Profiling Kits (4)
microRNA Inhibitors (1)
microRNA isolation kits (3)
microRNA labeling kits (0)
microRNA over expression Oligonucleotides (0)
microRNA over-expression constructs (built in a vector-based system) (2)
microRNA target mapping products (0)
microRNA transfection reagents (1)
Ancillary Reagents (0)
Barcode Labellers (1)
Contract Research (0)
Imaging Systems (3)
Isolation Kit (0)
Microarray Scanners (8)
Plate Stacking Systems (1)
qPCR Gene Expression Assays (0)
qPCR Gene Expression Reagents (0)
RNAi Vectors (0)
shRNA Libraries (8)
shRNA starter kits (0)
Control siRNA Reagents (0)
Custom siRNA Design (0)
Custom siRNA Synthesis (0)
Pre-designed siRNA (0)
siRNA delivery (5)
siRNA Expression Vectors (12)
siRNA Libraries (8)
siRNA Starter Kits (0)
Validated siRNA (0)
Cellmid Announces That British Journal of Pharmacology Features Midkine
BJP features midkine in a special edition with 16 new publications.
NexImmune’s AIM™ Technology Enables Novel Adoptive Immunotherapy Approach for Cancer Treatment
New scientific publication by NexImmune co-founder Dr. Jonathan Schneck.
Genetic Screening can Identify Men with Advanced Prostate Cancer
Screening of men who had multiple relatives with prostate cancer was able to pick up 13 mutations in known cancer genes that predicted the development of the disease.
Osteoporosis Drug May Treat Breast and Liver Cancers
Study from OSU has shown a drug used to prevent and treat osteoporosis in post-menopausal women may also be able to treat some breast and liver cancers.
Small Non-coding RNAs Could be Warning Signs of Cancer
Results are published in EMBO reports.
Major Advantages of Dako's HER2 IQFISH pharmDx™ in Breast Cancer Diagnostics
The Company announced positive findings in an independent French multicenter study on performance.
Studying Adhesion Forces Between Cancer Cells
JPK Instruments reports on the current cancer research project of Dr Florian T Ludwig at the Institute of Physiology II, University Hospital Münster, using a CellHesion® 200 to measure the adhesive forces between tumor cells.
Better RNAi, Inspired by Nature
New MIT nanoparticles offer best-ever gene silencing, could help treat liver diseases.
A Crisper View of DNA-Snipping Enzyme
HHMI scientists have created a portrait of a DNA-snipping protein called Cas9, a powerful research tool used in many labs for genome editing.
Regular Aspirin Use May Reduce Ovarian Cancer Risk
Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study from the National Cancer Institute.
Advertise On This Site
Terms & Conditions
©2014 Technology Networks
, all rights reserved.